Ernexa Therapeutics Inc. Earnings Per Share, Basic and Diluted
Ernexa Therapeutics Inc. (ERNA) reported Earnings Per Share, Basic and Diluted of -$1.51 per share for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-11.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2021-03-11
- Ernexa Therapeutics Inc. earnings per share, basic and diluted for the quarter ending 2020-12-31 was -$751.42.
- Ernexa Therapeutics Inc. earnings per share, basic and diluted for the quarter ending 2020-09-30 was -$0.50.
- Ernexa Therapeutics Inc. earnings per share, basic and diluted for the quarter ending 2020-06-30 was -$0.69.
- Ernexa Therapeutics Inc. earnings per share, basic and diluted for the quarter ending 2020-03-31 was -$0.42.
- Ernexa Therapeutics Inc. earnings per share, basic and diluted for fiscal 2020 was -$1.51.
- Ernexa Therapeutics Inc. earnings per share, basic and diluted for fiscal 2019 was -$0.72.
- Ernexa Therapeutics Inc. earnings per share, basic and diluted for fiscal 2018 was -$0.10.
- Ernexa Therapeutics Inc. earnings per share, basic and diluted for fiscal 2017 was -$0.45.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 3 month as first filed | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 6 month as first filed | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 9 month as first filed | Earnings Per Share, Basic and Diluted 12 month | Earnings Per Share, Basic and Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2020-12-31 | -$751.42 derived: net income ÷ weighted average shares · filed 2022-07-01 | -$1439.65 derived: net income ÷ weighted average shares · filed 2022-07-01 | -$6.42 derived: net income ÷ weighted average shares · filed 2022-07-01 | -$1.51 10-K · filed 2021-03-11 | ||||
| 2020-09-30 | -$0.50 10-Q · filed 2020-11-13 | -$2.77 derived: net income ÷ weighted average shares · filed 2021-11-12 | -$1.62 10-Q · filed 2020-11-13 | |||||
| 2020-06-30 | -$0.69 10-Q · filed 2020-08-07 | -$1.12 10-Q · filed 2020-08-07 | ||||||
| 2020-03-31 | -$0.42 10-Q · filed 2020-05-20 | |||||||
| 2019-12-31 | -$450.17 derived: net income ÷ weighted average shares · filed 2021-03-11 | -$573.21 derived: net income ÷ weighted average shares · filed 2021-03-11 | -$1.83 derived: net income ÷ weighted average shares · filed 2021-03-11 | -$0.72 10-K · filed 2021-03-11 | ||||
| 2019-09-30 | -$0.12 10-Q · filed 2020-11-13 | -$0.31 derived: net income ÷ weighted average shares · filed 2020-11-13 | -$0.27 10-Q · filed 2020-11-13 | |||||
| 2019-06-30 | -$0.03 10-Q · filed 2020-08-07 | -$0.11 10-Q · filed 2020-08-07 | -$0.14 10-Q · filed 2019-08-12 | |||||
| 2019-03-31 | -$0.11 10-Q · filed 2020-05-20 | |||||||
| 2018-12-31 | -$0.01 derived: net income ÷ weighted average shares · filed 2020-03-19 | -$0.11 derived: net income ÷ weighted average shares · filed 2020-03-19 | -$0.08 derived: net income ÷ weighted average shares · filed 2020-03-19 | -$0.10 10-K · filed 2020-03-19 | ||||
| 2018-09-30 | $0.08 10-Q · filed 2019-11-01 | $0.07 derived: net income ÷ weighted average shares · filed 2019-11-01 | -$0.12 10-Q · filed 2019-11-01 | |||||
| 2018-06-30 | -$0.05 10-Q · filed 2019-08-12 | -$0.22 10-Q · filed 2019-08-12 | -$0.21 10-Q · filed 2018-08-06 | |||||
| 2018-03-31 | -$0.16 10-Q · filed 2019-05-14 | |||||||
| 2017-12-31 | -$0.45 10-K · filed 2019-03-22 | -$0.44 10-K · filed 2018-03-09 | ||||||
| 2017-09-30 | -$0.07 10-Q · filed 2018-11-09 | -$0.18 10-Q · filed 2018-11-09 | ||||||
| 2017-06-30 | -$0.07 10-Q · filed 2018-08-06 | -$0.11 10-Q · filed 2018-08-06 | ||||||
| 2017-03-31 | -$0.04 10-Q · filed 2018-05-11 | |||||||
| 2016-12-31 | -$1.54 10-K · filed 2018-03-09 | |||||||
| 2016-09-30 | -$0.31 10-Q · filed 2017-11-08 | -$1.34 10-Q · filed 2017-11-08 | ||||||
| 2016-06-30 | -$0.46 10-Q · filed 2017-08-04 | -$1.03 10-Q · filed 2017-08-04 | ||||||
| 2016-03-31 | -$0.57 10-Q · filed 2017-05-04 | -$0.01 10-Q · filed 2016-05-09 | ||||||
| 2015-12-31 | -$3.93 10-K · filed 2017-03-09 | -$0.08 10-K · filed 2016-03-15 | ||||||
| 2015-09-30 | -$0.73 10-Q · filed 2016-11-09 | -$0.01 10-Q · filed 2015-11-09 | -$3.39 10-Q · filed 2016-11-09 | -$0.07 10-Q · filed 2015-11-09 | ||||
| 2015-06-30 | -$1.43 10-Q · filed 2016-08-04 | -$0.03 10-Q · filed 2015-08-10 | -$2.66 10-Q · filed 2016-08-04 | -$0.05 10-Q · filed 2015-08-10 | ||||
| 2015-03-31 | -$0.02 10-Q · filed 2016-05-09 | |||||||
| 2014-12-31 | -$0.06 10-K · filed 2016-03-15 | |||||||
| 2014-09-30 | -$0.01 10-Q · filed 2015-11-09 | -$0.04 10-Q · filed 2015-11-09 | ||||||
| 2014-06-30 | -$0.02 10-Q · filed 2015-08-10 | -$0.02 10-Q · filed 2015-08-10 | ||||||
| 2014-03-31 | -$0.01 10-Q · filed 2015-05-08 | |||||||
| 2013-12-31 | -$0.01 10-K · filed 2015-03-27 | |||||||
| 2013-09-30 | $0.00 10-Q · filed 2014-11-07 | -$0.01 10-Q · filed 2014-11-07 | ||||||
| 2013-06-30 | $0.00 10-Q · filed 2014-08-14 | -$0.01 10-Q · filed 2014-08-14 | ||||||
| 2013-03-31 | -$0.01 10-Q · filed 2014-05-15 | |||||||
| 2012-12-31 | $0.01 10-K · filed 2013-03-29 | -$0.01 10-K · filed 2014-03-31 | ||||||
| 2012-09-30 | $0.00 10-K · filed 2013-03-29 | |||||||
| 2012-06-30 | -$0.01 10-Q · filed 2013-08-14 | -$0.02 10-Q · filed 2013-08-14 | ||||||
| 2012-03-31 | -$0.02 10-Q · filed 2013-05-13 | |||||||
| 2011-12-31 | -$0.02 10-K · filed 2013-03-29 | -$0.06 10-K · filed 2013-03-29 | ||||||
| 2011-09-30 | -$0.01 10-K · filed 2013-03-29 | |||||||
| 2011-06-30 | -$0.02 10-K · filed 2013-03-29 | -$0.03 10-Q · filed 2012-08-14 | ||||||
| 2011-03-31 | -$0.01 10-K · filed 2013-03-29 | |||||||
| 2010-12-31 | -$0.01 10-K · filed 2012-03-30 | |||||||
| 2010-06-30 | -$0.01 10-Q · filed 2011-08-12 | -$0.01 10-Q · filed 2011-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |